Your browser doesn't support javascript.
loading
Alpha-synuclein ferrireductase activity is detectible in vivo, is altered in Parkinson's disease and increases the neurotoxicity of DOPAL.
McDowall, Jennifer S; Ntai, Ioanna; Honeychurch, Kevin C; Hart, John P; Colin, Philippe; Schneider, Bernard L; Brown, David R.
Afiliação
  • McDowall JS; Department of Biology and Biochemistry, University of Bath, Bath, UK.
  • Ntai I; Department of Biology and Biochemistry, University of Bath, Bath, UK.
  • Honeychurch KC; Department of Biological, Biomedical and Analytical Sciences, Faculty of Health and Applied Sciences, University of the West of England, Bristol, UK.
  • Hart JP; Department of Biological, Biomedical and Analytical Sciences, Faculty of Health and Applied Sciences, University of the West of England, Bristol, UK.
  • Colin P; Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne 1015, Switzerland.
  • Schneider BL; Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne 1015, Switzerland.
  • Brown DR; Department of Biology and Biochemistry, University of Bath, Bath, UK. Electronic address: bssdrb@bath.ac.uk.
Mol Cell Neurosci ; 85: 1-11, 2017 12.
Article em En | MEDLINE | ID: mdl-28811225

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Encéfalo / Alfa-Sinucleína Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Encéfalo / Alfa-Sinucleína Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article